Steven George Hughes insider trades

Open-market stock purchases and sales by Steven George Hughes, Chief Medical Officer at Atrium Therapeutics, Inc, from SEC Form 4 filings since Aug 14, 2018.

Recent trades

DateStockTradeValue
Sep 18, 2026RNA Atrium Therapeutics, IncSold (not open market)$192K
Apr 20, 2026RNA Atrium Therapeutics, IncBought (not open market)—
Apr 20, 2026RNA Atrium Therapeutics, IncBought (not open market)—
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$1.2M
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$1.7M
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$324K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$696K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$1.6M
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)—
Jan 21, 2026RNA Avidity Biosciences, IncSold$146K
Jan 21, 2026RNA Avidity Biosciences, IncSold$209K
Jan 7, 2026RNA Avidity Biosciences, IncSold$171K

Companies traded

  • RNA Atrium Therapeutics, Inc: 16 sales, last Sep 18, 2026
  • RNAM Avidity Biosciences, Inc: other filings, last Feb 27, 2026
  • ARCT Arcturus Therapeutics Holdings Inc: other filings, last Dec 18, 2020
  • ONVO Organovo Holdings, Inc: 1 sale, last Aug 16, 2019

Get free alerts when Steven George Hughes files a new trade →